Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateTimeSourceHeadlineSymbolCompany
06/24/20204:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/24/20204:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/24/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/24/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/24/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/18/20207:54PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:YMABY mAbs Therapeutics Inc
06/16/20206:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/12/20207:36PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:YMABY mAbs Therapeutics Inc
06/12/20204:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
06/05/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/02/20209:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
06/02/20209:00AMGlobeNewswire Inc.Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelzaâ„¢ (naxitamab) for the Treatment of Neurob...NASDAQ:YMABY mAbs Therapeutics Inc
05/29/20204:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/27/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/20/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/20/20204:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/15/20204:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/15/20204:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/15/20204:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/14/20204:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/13/20204:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/13/20209:00AMGlobeNewswire Inc.Y-mAbs Announces Data to be Presented at 2020 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
05/07/20204:42PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMABY mAbs Therapeutics Inc
05/07/20204:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
05/07/20204:01PMGlobeNewswire Inc.Y-mAbs Announces First Quarter 2020 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
05/05/20204:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
04/30/20209:56AMGlobeNewswire Inc.UPDATE - Y-mAbs to Announce First Quarter 2020 Financial and Operating Results on May 7, 2020NASDAQ:YMABY mAbs Therapeutics Inc
04/30/20209:00AMGlobeNewswire Inc.Y-mAbs to Announce 2019 Financial and Operating Results on May 7, 2020NASDAQ:YMABY mAbs Therapeutics Inc
04/28/20206:16AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMABY mAbs Therapeutics Inc
04/28/20206:12AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB

Your Recent History

Delayed Upgrade Clock